Course type: Online; Self-Paced
Duration: Available for 2 months
Time required: Up to 1 hour per module
Target Audience: Healthcare Professionals, Nurses
Level: Basic to Advanced
Language: English and Portuguese
This course prepares you to recognize the different types of internationally approved COVID-19 vaccines, to be prepared to manage possible complications, and to know how to act, stabilize, diagnose and treat patients with these complications.
About the COVID-19 Vaccination Course
In March 2020, the World Health Organization declared that the COVID-19 virus was officially a pandemic. The onset and lethality of the disease led to the need to create a vaccine in order to provide acquired immunity against the virus.
Based on current international guidelines for different types of internationally approved COVID-19 vaccines, this course aims to provide healthcare professionals with adequate knowledge and skills to ensure a safe and efficient administration of the COVID-19 vaccine.
The need to standardize the practices of health professionals through the different types of vaccines presented led the International Red Cross and Body Interact to offer this unique simulation training opportunity.
- 4 Modules
The course consists of 4 modules with virtual patient cases, with increasing level of complexity.
- Online, Self-paced
You have up to 2 months to complete the 4 modules at your own pace.
- Certificate of Completion
After completing the course, you will be given a Certificate of Completion.
What you will learn:
By undertaking this course, healthcare professionals and students will be prepared to:
- Perform accurate assessment/clinical consideration questions in pre vaccination.
- Understand the contraindications due to allergies for not administering the COVID-19 vaccine.
- Prepare and select the unit dose of COVID-19 vaccine
- Administer the COVID-19 vaccine.
- Identify and treat an anaphylactic reaction
- Search for alarm signals in the physiological parameters (signs of respiratory difficulty, hypoxia, wheezing, stridor, rash, signs of hypoperfusion) and promote their correction.
- Notify allergic reactions.
The Portuguese Red Cross in conjunction with the International Red Cross and Body Interact, have developed this course utilising Body Interact’s advanced medical simulation technology.
Professor Leila Sales
Expert on Patient Safety Education and Training
Red Cross Higher School of Health
Context: COVID-19 reached tens of millions of people in a worldwide pandemic. Safe and effective prophylactic vaccines are urgently needed to contain the pandemic, which has had devastating consequences. mRNA vaccines contain virus material that causes COVID-19, providing cells with information on how to make a harmless protein that is unique to the virus.
This module provides information on the selection of the unit dose of the COVID-19 mRNA vaccine, taking into account its need for dilution and the time interval between doses.
Virtual Scenario: Mr. Gaines was contacted to receive his first dose of vaccine against COVID-19 since he belongs to the priority group.
Context: The mRNA-1273 immunization vaccine provides messenger RNA, or mRNA, which is a genetic recipe for making a piece of the tips that are on top of the coronavirus. Once injected, the body’s immune system produces antibodies against the virus.
The mRNA-1273 vaccine, in particular, contains a synthetic mRNA that encodes a structure called “pre-fused stabilized peak glycoprotein” of the virus.
This module helps health professionals to act on mRNA type vaccines, preparing them to respond according to the specifics of the vaccines.
Virtual Scenario: Mrs. Rossi is a health worker in an Intensive Care Unit for more than 10 years. She has had difficult times over the last months and today was contacted to receive her first dose of the vaccine against COVID-19.
Context: Vector vaccines contain a weakened version of a live virus – a different virus from the one that causes COVID-19 – which has genetic material from the virus that causes COVID-19 to be inserted into it (this is called a viral vector).
This module provides an overview of the specifics of this type of vaccine.
Virtual Scenario: Ms. Holt is a nurse in a nursing home and she was contacted to receive her first dose of the vaccine against COVID-19.
Context: Adverse events can occur in any recipient after vaccination with the different types of COVID-19. It is essential that health professionals are familiar with the identification of allergic reactions, early identifying signs and symptoms, and being competent in the treatment of these events.
Virtual Scenario: Ms. Smith worked for many years as a clinical secretary in the hospital, but she also retired due to her health conditions, as she has a personal history of hypertension and chronic obstructive pulmonary disease. Today she went to the health center to be vaccinated against covid-19.